
    
      Subjects with Fuchs endothelial dystrophy will have the central corneal endothelium and
      guttae-covered Descemet membrane surgically removed. Subjects will be randomized to use
      netarsudil or placebo eye drops once daily. Visual acuity, corneal clearing and central
      endothelial cell density will be monitored for the 3-month study duration.
    
  